Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127766921 | 12776692 | 1 | I | 2011 | 20160620 | 20160923 | 20160923 | EXP | DE-MYLANLABS-2016M1040359 | MYLAN | THERAPY-RESISTANT MAJOR DEPRESSION.. JOURNAL NEUROTRANSMITTER. 2016;27(6):50-1 | 0.00 | Y | 0.00000 | 20160923 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127766921 | 12776692 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | 200 MG, QD | U | U | 75417 | 200 | MG | QD | ||||||
| 127766921 | 12776692 | 2 | SS | NORTRIPTYLINE | NORTRIPTYLINE | 1 | U | 0 | |||||||||||
| 127766921 | 12776692 | 3 | SS | DULOXETINE. | DULOXETINE | 1 | 120 MG, QD | U | U | 0 | 120 | MG | QD | ||||||
| 127766921 | 12776692 | 4 | SS | AMISULPRIDE | AMISULPRIDE | 1 | 100 MG, QD | U | U | 0 | 100 | MG | QD | ||||||
| 127766921 | 12776692 | 5 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | U | 0 | ||||||||||
| 127766921 | 12776692 | 6 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | U | U | 0 | ||||||||||
| 127766921 | 12776692 | 7 | SS | BUPROPION. | BUPROPION | 1 | U | U | 0 | ||||||||||
| 127766921 | 12776692 | 8 | SS | QUETIAPINE. | QUETIAPINE | 1 | U | 0 | |||||||||||
| 127766921 | 12776692 | 9 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | U | 0 | |||||||||||
| 127766921 | 12776692 | 10 | SS | LITHIUM. | LITHIUM | 1 | U | U | 0 | ||||||||||
| 127766921 | 12776692 | 11 | SS | AGOMELATIN | AGOMELATINE | 1 | U | 0 | |||||||||||
| 127766921 | 12776692 | 12 | SS | REBOXETINE | REBOXETINE | 1 | 6 MG, QD | U | U | 0 | 6 | MG | QD | ||||||
| 127766921 | 12776692 | 13 | SS | VORTIOXETINE | VORTIOXETINE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127766921 | 12776692 | 1 | Depression |
| 127766921 | 12776692 | 2 | Depression |
| 127766921 | 12776692 | 3 | Depression |
| 127766921 | 12776692 | 4 | Depression |
| 127766921 | 12776692 | 5 | Depression |
| 127766921 | 12776692 | 6 | Depression |
| 127766921 | 12776692 | 7 | Depression |
| 127766921 | 12776692 | 8 | Depression |
| 127766921 | 12776692 | 9 | Depression |
| 127766921 | 12776692 | 10 | Depression |
| 127766921 | 12776692 | 11 | Depression |
| 127766921 | 12776692 | 12 | Depression |
| 127766921 | 12776692 | 13 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127766921 | 12776692 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127766921 | 12776692 | Depressive symptom | |
| 127766921 | 12776692 | Drug ineffective | |
| 127766921 | 12776692 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |